Evidence map›Paper›PMID 42276980›Full record

ArticleTranslational psychiatry2026

Divergent transcriptomic pathways underlie sex-biased cognitive rescue by developmental GSK3B inhibition in a mouse model of 22q11.2 deletion syndrome.

Johannes Passecker, Chia-Yuan Chang, Aleksandra Dagunts, Chloe M Aloimonos, Lukas Leitner, Arsenii Petryk, Florence F Wagner, Maxym V Myroshnychenko, David A Kupferschmidt, Joseph A Gogos and 1 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Johannes PasseckerIntegrative Neuroscience Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA. johannes.passecker@i-med.ac.at.
Chia-Yuan ChangMortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY, 10027, USA.ORCID http://orcid.org/0000-0002-5912-9234
Aleksandra DaguntsIntegrative Neuroscience Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA.
Chloe M AloimonosIntegrative Neuroscience Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA.
Lukas LeitnerInstitute of Systems Neuroscience, Medical University of Innsbruck, Innsbruck, Austria.
Arsenii PetrykInstitute of Systems Neuroscience, Medical University of Innsbruck, Innsbruck, Austria.
Florence F WagnerThe Broad Institute of MIT and Harvard Center for the Development of Therapeutics, Cambridge, MA, 02142, USA.
Maxym V MyroshnychenkoIntegrative Neuroscience Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA.
David A KupferschmidtIntegrative Neuroscience Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA.
Joseph A GogosMortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY, 10027, USA. jag90@columbia.edu.ORCID http://orcid.org/0000-0002-7491-4476
Joshua A GordonIntegrative Neuroscience Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA.ORCID http://orcid.org/0000-0002-5488-8266

Funding

Mechanisms underlying the functional connectivity deficit in the 22q11 microdeletR01MH096274 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GOGOS, JOSEPH A · 2012 to 2021
$3.6M
Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) P35747Brain and Behavior Research Foundation (Brain & Behavior Research Foundation) 28622NIMH NIH HHS R01 MH096274U.S. Department of Health & Human Services | National Institutes of Health (NIH) 5R01MH096274-08U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS003168
6 · The paper itself

Abstract

Neuropsychiatric disorders such as schizophrenia frequently exhibit marked sex differences in onset, clinical features, and treatment response. However, the molecular and developmental bases of these differences remain poorly defined. Here, we report a sex-dependent effect of developmental, paralog-selective GSK3B inhibition on working memory (WM) in the Df(16)A

Indexed as

DiGeorge SyndromeGlycogen Synthase Kinase 3 betaMemory, Short-TermTranscriptomeAnimalsDisease Models, AnimalFemaleHippocampusMaleMicePrefrontal CortexSchizophreniaSex CharacteristicsSex FactorsGlycogen Synthase Kinase 3 beta

Identifiers

PMID42276980
PMCPMC13478295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.